AIM ImmunoTech Competitors and Similar CompaniesClear all
AIM ImmunoTech's competitors and similar companies include ImmuneSensor Therapeutics, CytomX Therapeutics, Carrick Therapeutics and NMS Group.
 AIM ImmunoTech AIM ImmunoTech (formerly known as Hemispherx Biopharma) is an immuno-tech company focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases. |  ImmuneSensor Therapeutics ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Carrick Therapeutics Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments. |  NMS Group NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs. | |
Founding Date | Founding Date 1990 | Founding Date 2014 | Founding Date 2008 | Founding Date 2015 | Founding Date N/A |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Ocala, US HQ New Brunswick, US | Locations Dallas, US HQ | Locations South San Francisco, US HQ | Locations Dublin, IE HQ Oxford, GB | Locations Nerviano, IT HQ |
Employees | Employees 3124% increase | Employees 11 | Employees 15815% increase | Employees 17 | Employees 76 |
Valuation ($) | Valuation ($) 17.1 m | Valuation ($) N/A | Valuation ($) 78 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $88k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($14m) (FY, 2025) | Net income N/A | Net income ($17.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 132.4m | Total funding raised $ 95m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ImmuneSensor Therapeutics
HQ
Dallas, US
Employees
11
ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases.
View companyCytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companyCarrick Therapeutics
HQ
Dublin, IE
Employees
17
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments.
View companyNMS Group
HQ
Nerviano, IT
Employees
76
NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs.
View company